G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 97 filers reported holding G1 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9 | -43.8% | 6,302 | 0.0% | 0.00% | – |
| Q2 2023 | $16 | -30.4% | 6,302 | -28.1% | 0.00% | – |
| Q1 2023 | $23 | -84.0% | 8,765 | -66.9% | 0.00% | – |
| Q4 2022 | $144 | -100.0% | 26,475 | -76.7% | 0.00% | -100.0% |
| Q3 2022 | $1,420,000 | +70900.0% | 113,631 | +50628.1% | 0.00% | – |
| Q1 2022 | $2,000 | -99.9% | 224 | -99.8% | 0.00% | – |
| Q4 2021 | $1,338,000 | +497.3% | 131,026 | +683.4% | 0.00% | – |
| Q3 2021 | $224,000 | +11100.0% | 16,725 | +17142.3% | 0.00% | – |
| Q2 2021 | $2,000 | -75.0% | 97 | -71.0% | 0.00% | – |
| Q1 2021 | $8,000 | -99.5% | 334 | -99.6% | 0.00% | -100.0% |
| Q4 2020 | $1,658,000 | +646.8% | 92,152 | +377.5% | 0.00% | – |
| Q3 2020 | $222,000 | -61.7% | 19,298 | -19.3% | 0.00% | – |
| Q2 2020 | $579,000 | +1013.5% | 23,904 | +402.0% | 0.00% | – |
| Q1 2020 | $52,000 | -95.4% | 4,762 | -88.9% | 0.00% | -100.0% |
| Q4 2019 | $1,133,000 | +828.7% | 42,872 | +702.7% | 0.00% | – |
| Q3 2019 | $122,000 | -84.5% | 5,341 | -79.2% | 0.00% | – |
| Q2 2019 | $789,000 | +681.2% | 25,723 | +320.2% | 0.00% | – |
| Q1 2019 | $101,000 | +83.6% | 6,121 | +114.4% | 0.00% | – |
| Q4 2018 | $55,000 | -94.8% | 2,855 | -86.0% | 0.00% | -100.0% |
| Q3 2018 | $1,065,000 | +569.8% | 20,370 | +455.5% | 0.00% | – |
| Q2 2018 | $159,000 | +28.2% | 3,667 | +9.5% | 0.00% | – |
| Q1 2018 | $124,000 | +53.1% | 3,348 | -17.9% | 0.00% | – |
| Q4 2017 | $81,000 | -31.4% | 4,077 | -13.6% | 0.00% | – |
| Q3 2017 | $118,000 | +742.9% | 4,719 | +489.9% | 0.00% | – |
| Q2 2017 | $14,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |